Concepedia

Gary Hantsbarger

GH

Statistics

Publications

12

Citations

960

H-Index

11

Active since

1992

Affiliations

Takeda (United States)(Current)

Takeda (Switzerland)

University of Cincinnati Medical Center

Ohio Heart & Vascular Center

St. Luke's Episcopal Hospital

Gary Hantsbarger is an author at Takeda (United States) specializing in medicine, pharmacology, and clinical pharmacology.

Publications per year

1992–2023

12

Publications

12

Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration

Jeffrey S. Heier, Andrew N. Antoszyk, Peter R. Pavan et al. · Ophthalmology · 2006 · 361 citations

, , +10

Tolerability and Efficacy of Multiple Escalating Doses of Ranibizumab (Lucentis) for Neovascular Age-Related Macular Degeneration

Philip J. Rosenfeld, Jeffrey S. Heier, Gary Hantsbarger et al. · Ophthalmology · 2006 · 189 citations

, , +12

Pharmacodynamic Efficacy, Clinical Safety, and Outcomes After Prolonged Platelet Glycoprotein IIb/IIIa Receptor Blockade With Oral Xemilofiban

Dean J. Kereiakes, Neal S. Kleiman, James J. Ferguson et al. · Circulation · 1998 · 96 citations · Full text

, , +17

Sustained Platelet Glycoprotein IIb/IIIa Blockade With Oral Xemilofiban in 170 Patients After Coronary Stent Deployment

Dean J. Kereiakes, Neal S. Kleiman, James J. Ferguson et al. · Circulation · 1997 · 71 citations

, , +17

Differential Dose-Response to Oral Xemilofiban After Antecedent Intravenous Abciximab

Dean J. Kereiakes, John Paul Runyon, Neal S. Kleiman et al. · Circulation · 1996 · 63 citations

, , +17

1–5 of 12